NCT07251738Not yet recruiting
Understanding the Lived Experience and Bereavement of Caregivers of People With Alzheimer's Disease
Source: ClinicalTrials.gov · Last updated 26 Nov 2025
Brief summary (registry, in English)
The main objective of this study is to explore the lived experience of caregivers and family members of people with Alzheimer's disease (AD), from the beginning of caregiving through the bereavement process following the patient's death. Using a mixed-methods design, qualitative data will be collected through in-depth interviews and combined with quantitative data obtained from standardized scales. The results will aim to determine whether prolonged caregiving significantly affects the caregiver's or family member's personal, emotional, and occupational well-being, as well as whether it leads to a reorganization of activities of daily living (ADL), an increased perception of burden, and/or a decreased quality of life. The study will also examine the presence of positive adaptation experiences.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 66 (estimated)
- First submitted
- 18 Nov 2025
- Start date
- 1 Dec 2025
- Primary completion date
- 31 May 2026
- Lead sponsor
- Universidad Rey Juan Carlos
- Diseases
- Alzheimer disease
- NCT number
- NCT07251738
What you commit to
- Study type: Observational
- Planned participants: 66
- From 1 Dec 2025 to the primary completion date, 31 May 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Those who have not lived with or cared for relatives with AD and who do not agree to participate in the study will be excluded from the project.
Who the study is looking for
- Inclusion criteria for Group 1: relatives of people diagnosed with AD by a neurologist or geriatrician, who have suffered the loss of a relative with AD; who have lived with and/or cared for the person with AD until the end of their life; who agree to participate voluntarily in the project and who have signed the informed consent form.
- Inclusion criteria for Group 2: relatives of people diagnosed with AD by a neurologist or geriatrician; who live with and/or care for the person with AD; who attend the Day Centre and who agree to participate voluntarily in the project and have signed the informed consent form.
- Inclusion criteria for Group 3: relatives of people diagnosed with AD by a neurologist or geriatrician; who have their relative institutionalised in a nursing home and who agree to participate voluntarily in the project and have signed the informed consent form.
Sex: All · Accepts healthy volunteers
Related publications
- Understanding the Lived Experience and Bereavement of Caregivers of People with Alzheimer's Disease: A Mixed-Methods Study Protocol.Healthcare (Basel) · 2026 · PMID 41975901
This page is information, not medical advice. Discuss any trial with your doctor.